nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobetasol propionate—NR3C1—Medroxyprogesterone Acetate—uterine cancer	0.193	0.432	CbGbCtD
Clobetasol propionate—NR3C1—Progesterone—uterine cancer	0.128	0.286	CbGbCtD
Clobetasol propionate—CYP1A1—Progesterone—uterine cancer	0.0761	0.171	CbGbCtD
Clobetasol propionate—Prednicarbate—Medroxyprogesterone Acetate—uterine cancer	0.0747	0.15	CrCrCtD
Clobetasol propionate—Fluoxymesterone—Medroxyprogesterone Acetate—uterine cancer	0.0686	0.138	CrCrCtD
Clobetasol propionate—Fludrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.0668	0.134	CrCrCtD
Clobetasol propionate—Fluorometholone—Medroxyprogesterone Acetate—uterine cancer	0.0621	0.125	CrCrCtD
Clobetasol propionate—Fluoxymesterone—Progesterone—uterine cancer	0.0598	0.12	CrCrCtD
Clobetasol propionate—Fludrocortisone—Progesterone—uterine cancer	0.0583	0.117	CrCrCtD
Clobetasol propionate—Methylprednisolone—Medroxyprogesterone Acetate—uterine cancer	0.058	0.117	CrCrCtD
Clobetasol propionate—Prednisolone—Progesterone—uterine cancer	0.0495	0.0995	CrCrCtD
Clobetasol propionate—CYP1A2—Progesterone—uterine cancer	0.034	0.0763	CbGbCtD
Clobetasol propionate—CYP1A2—Etoposide—uterine cancer	0.0152	0.0341	CbGbCtD
Clobetasol propionate—Cushing's syndrome—Medroxyprogesterone Acetate—uterine cancer	0.00365	0.0925	CcSEcCtD
Clobetasol propionate—Eruption—Dactinomycin—uterine cancer	0.00105	0.0266	CcSEcCtD
Clobetasol propionate—Tenderness—Progesterone—uterine cancer	0.00105	0.0266	CcSEcCtD
Clobetasol propionate—Folliculitis—Dactinomycin—uterine cancer	0.00103	0.0261	CcSEcCtD
Clobetasol propionate—Glycosuria—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.0259	CcSEcCtD
Clobetasol propionate—Tenderness—Medroxyprogesterone Acetate—uterine cancer	0.000949	0.0241	CcSEcCtD
Clobetasol propionate—Secondary infection—Epirubicin—uterine cancer	0.000892	0.0226	CcSEcCtD
Clobetasol propionate—Secondary infection—Doxorubicin—uterine cancer	0.000825	0.0209	CcSEcCtD
Clobetasol propionate—CYP1A1—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.000742	0.067	CbGpPWpGaD
Clobetasol propionate—Vascular purpura—Progesterone—uterine cancer	0.000742	0.0188	CcSEcCtD
Clobetasol propionate—Purpura—Progesterone—uterine cancer	0.000688	0.0175	CcSEcCtD
Clobetasol propionate—Pain in extremity—Progesterone—uterine cancer	0.000663	0.0168	CcSEcCtD
Clobetasol propionate—Purpura—Medroxyprogesterone Acetate—uterine cancer	0.000624	0.0158	CcSEcCtD
Clobetasol propionate—Infection—Carboplatin—uterine cancer	0.000617	0.0156	CcSEcCtD
Clobetasol propionate—Leukoderma—Epirubicin—uterine cancer	0.000617	0.0156	CcSEcCtD
Clobetasol propionate—Pain in extremity—Medroxyprogesterone Acetate—uterine cancer	0.000601	0.0152	CcSEcCtD
Clobetasol propionate—Tingling sensation—Etoposide—uterine cancer	0.000582	0.0147	CcSEcCtD
Clobetasol propionate—CYP1A1—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.000571	0.0516	CbGpPWpGaD
Clobetasol propionate—Leukoderma—Doxorubicin—uterine cancer	0.00057	0.0145	CcSEcCtD
Clobetasol propionate—Dry skin—Medroxyprogesterone Acetate—uterine cancer	0.000551	0.014	CcSEcCtD
Clobetasol propionate—Pain—Carboplatin—uterine cancer	0.000531	0.0135	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Progesterone—uterine cancer	0.000517	0.0131	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.000469	0.0119	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Progesterone—uterine cancer	0.000452	0.0115	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Progesterone—uterine cancer	0.000451	0.0114	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Epirubicin—uterine cancer	0.000441	0.0112	CcSEcCtD
Clobetasol propionate—Eruption—Epirubicin—uterine cancer	0.000426	0.0108	CcSEcCtD
Clobetasol propionate—Folliculitis—Epirubicin—uterine cancer	0.000417	0.0106	CcSEcCtD
Clobetasol propionate—Psoriasis—Epirubicin—uterine cancer	0.000417	0.0106	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00041	0.0104	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.000409	0.0104	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Doxorubicin—uterine cancer	0.000408	0.0103	CcSEcCtD
Clobetasol propionate—Alopecia—Progesterone—uterine cancer	0.000406	0.0103	CcSEcCtD
Clobetasol propionate—Erythema—Progesterone—uterine cancer	0.0004	0.0101	CcSEcCtD
Clobetasol propionate—Fluticasone Propionate—PGR—uterine cancer	0.000395	0.204	CrCbGaD
Clobetasol propionate—Eruption—Doxorubicin—uterine cancer	0.000394	0.01	CcSEcCtD
Clobetasol propionate—Psoriasis—Doxorubicin—uterine cancer	0.000386	0.00978	CcSEcCtD
Clobetasol propionate—Folliculitis—Doxorubicin—uterine cancer	0.000386	0.00978	CcSEcCtD
Clobetasol propionate—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.000368	0.00932	CcSEcCtD
Clobetasol propionate—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.000362	0.00918	CcSEcCtD
Clobetasol propionate—Betamethasone—PGR—uterine cancer	0.000362	0.187	CrCbGaD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.000338	0.00856	CcSEcCtD
Clobetasol propionate—Rash pustular—Epirubicin—uterine cancer	0.000329	0.00833	CcSEcCtD
Clobetasol propionate—Infection—Progesterone—uterine cancer	0.000324	0.00821	CcSEcCtD
Clobetasol propionate—Stinging—Epirubicin—uterine cancer	0.000324	0.0082	CcSEcCtD
Clobetasol propionate—Glycosuria—Epirubicin—uterine cancer	0.000324	0.0082	CcSEcCtD
Clobetasol propionate—Skin disorder—Progesterone—uterine cancer	0.000317	0.00803	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000306	0.00776	CcSEcCtD
Clobetasol propionate—Rash pustular—Doxorubicin—uterine cancer	0.000304	0.00771	CcSEcCtD
Clobetasol propionate—Stinging—Doxorubicin—uterine cancer	0.000299	0.00759	CcSEcCtD
Clobetasol propionate—Glycosuria—Doxorubicin—uterine cancer	0.000299	0.00759	CcSEcCtD
Clobetasol propionate—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000294	0.00744	CcSEcCtD
Clobetasol propionate—Fluoxymesterone—ESR1—uterine cancer	0.000293	0.152	CrCbGaD
Clobetasol propionate—Paraesthesia—Progesterone—uterine cancer	0.000293	0.00742	CcSEcCtD
Clobetasol propionate—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000287	0.00728	CcSEcCtD
Clobetasol propionate—Alopecia—Dactinomycin—uterine cancer	0.000287	0.00727	CcSEcCtD
Clobetasol propionate—Erythema—Dactinomycin—uterine cancer	0.000282	0.00716	CcSEcCtD
Clobetasol propionate—Dexamethasone—CYP11A1—uterine cancer	0.000279	0.144	CrCbGaD
Clobetasol propionate—Pain—Progesterone—uterine cancer	0.000279	0.00707	CcSEcCtD
Clobetasol propionate—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000265	0.00673	CcSEcCtD
Clobetasol propionate—NR3C1—Nuclear Receptors—PGR—uterine cancer	0.000261	0.0236	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Oxidative Stress—NFE2L2—uterine cancer	0.000261	0.0235	CbGpPWpGaD
Clobetasol propionate—Dermatitis contact—Epirubicin—uterine cancer	0.000259	0.00657	CcSEcCtD
Clobetasol propionate—NR3C1—Signaling events mediated by HDAC Class II—YWHAE—uterine cancer	0.000249	0.0225	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Oxidative Stress—GPX3—uterine cancer	0.000249	0.0224	CbGpPWpGaD
Clobetasol propionate—Betamethasone—CYP19A1—uterine cancer	0.000248	0.128	CrCbGaD
Clobetasol propionate—NR3C1—myometrium—uterine cancer	0.000246	0.0652	CbGeAlD
Clobetasol propionate—NR3C1—Endoderm Differentiation—HNF1B—uterine cancer	0.000243	0.0219	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Progesterone—uterine cancer	0.00024	0.00609	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Doxorubicin—uterine cancer	0.00024	0.00608	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Etoposide—uterine cancer	0.000234	0.00592	CcSEcCtD
Clobetasol propionate—Pruritus—Progesterone—uterine cancer	0.000231	0.00585	CcSEcCtD
Clobetasol propionate—NR3C1—Nuclear Receptors—ESR2—uterine cancer	0.00023	0.0208	CbGpPWpGaD
Clobetasol propionate—Infection—Dactinomycin—uterine cancer	0.000229	0.00581	CcSEcCtD
Clobetasol propionate—CYP1A1—Estrogen Receptor Pathway—ESR1—uterine cancer	0.000221	0.02	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000218	0.00552	CcSEcCtD
Clobetasol propionate—Vascular purpura—Epirubicin—uterine cancer	0.000213	0.00539	CcSEcCtD
Clobetasol propionate—Dexamethasone—PGR—uterine cancer	0.00021	0.109	CrCbGaD
Clobetasol propionate—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000209	0.0053	CcSEcCtD
Clobetasol propionate—Alopecia—Etoposide—uterine cancer	0.000207	0.00526	CcSEcCtD
Clobetasol propionate—NR3C1—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.000207	0.0186	CbGpPWpGaD
Clobetasol propionate—Rash—Progesterone—uterine cancer	0.000206	0.00521	CcSEcCtD
Clobetasol propionate—Dermatitis—Progesterone—uterine cancer	0.000205	0.00521	CcSEcCtD
Clobetasol propionate—Headache—Progesterone—uterine cancer	0.000204	0.00518	CcSEcCtD
Clobetasol propionate—CYP1A1—epithelium—uterine cancer	0.000199	0.0527	CbGeAlD
Clobetasol propionate—Purpura—Epirubicin—uterine cancer	0.000197	0.005	CcSEcCtD
Clobetasol propionate—CYP1A1—uterine cervix—uterine cancer	0.000197	0.0523	CbGeAlD
Clobetasol propionate—Pain—Dactinomycin—uterine cancer	0.000197	0.005	CcSEcCtD
Clobetasol propionate—Vascular purpura—Doxorubicin—uterine cancer	0.000197	0.00499	CcSEcCtD
Clobetasol propionate—NR3C1—epithelium—uterine cancer	0.000193	0.0512	CbGeAlD
Clobetasol propionate—NR3C1—uterine cervix—uterine cancer	0.000192	0.0507	CbGeAlD
Clobetasol propionate—Pain in extremity—Epirubicin—uterine cancer	0.00019	0.00482	CcSEcCtD
Clobetasol propionate—CYP1A2—renal system—uterine cancer	0.000187	0.0496	CbGeAlD
Clobetasol propionate—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000186	0.00472	CcSEcCtD
Clobetasol propionate—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000186	0.00472	CcSEcCtD
Clobetasol propionate—NR3C1—smooth muscle tissue—uterine cancer	0.000186	0.0493	CbGeAlD
Clobetasol propionate—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000185	0.00469	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—NFE2L2—uterine cancer	0.000185	0.0167	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—NFE2L2—uterine cancer	0.000185	0.0167	CbGpPWpGaD
Clobetasol propionate—CYP1A1—renal system—uterine cancer	0.000185	0.0489	CbGeAlD
Clobetasol propionate—Purpura—Doxorubicin—uterine cancer	0.000183	0.00463	CcSEcCtD
Clobetasol propionate—NR3C1—decidua—uterine cancer	0.000182	0.0483	CbGeAlD
Clobetasol propionate—NR3C1—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.000182	0.0164	CbGpPWpGaD
Clobetasol propionate—NR3C1—renal system—uterine cancer	0.000179	0.0475	CbGeAlD
Clobetasol propionate—Pain in extremity—Doxorubicin—uterine cancer	0.000176	0.00446	CcSEcCtD
Clobetasol propionate—Dry skin—Epirubicin—uterine cancer	0.000174	0.00442	CcSEcCtD
Clobetasol propionate—NR3C1—endometrium—uterine cancer	0.000173	0.0459	CbGeAlD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000173	0.00438	CcSEcCtD
Clobetasol propionate—CYP1A1—mammalian vulva—uterine cancer	0.000173	0.0457	CbGeAlD
Clobetasol propionate—Hypersensitivity—Dactinomycin—uterine cancer	0.00017	0.00431	CcSEcCtD
Clobetasol propionate—NR3C1—mammalian vulva—uterine cancer	0.000168	0.0444	CbGeAlD
Clobetasol propionate—Infection—Etoposide—uterine cancer	0.000166	0.0042	CcSEcCtD
Clobetasol propionate—CYP1A1—uterus—uterine cancer	0.000165	0.0436	CbGeAlD
Clobetasol propionate—Skin disorder—Etoposide—uterine cancer	0.000162	0.00411	CcSEcCtD
Clobetasol propionate—Dry skin—Doxorubicin—uterine cancer	0.000161	0.00409	CcSEcCtD
Clobetasol propionate—NR3C1—uterus—uterine cancer	0.00016	0.0423	CbGeAlD
Clobetasol propionate—NR3C1—Endoderm Differentiation—EZH2—uterine cancer	0.000156	0.0141	CbGpPWpGaD
Clobetasol propionate—Paraesthesia—Etoposide—uterine cancer	0.00015	0.0038	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Epirubicin—uterine cancer	0.000148	0.00376	CcSEcCtD
Clobetasol propionate—CYP1A1—female reproductive system—uterine cancer	0.000148	0.0392	CbGeAlD
Clobetasol propionate—Rash—Dactinomycin—uterine cancer	0.000145	0.00368	CcSEcCtD
Clobetasol propionate—CYP1A1—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000145	0.0131	CbGpPWpGaD
Clobetasol propionate—Dexamethasone—CYP19A1—uterine cancer	0.000144	0.0747	CrCbGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—IRF1—uterine cancer	0.000144	0.013	CbGpPWpGaD
Clobetasol propionate—NR3C1—female reproductive system—uterine cancer	0.000143	0.038	CbGeAlD
Clobetasol propionate—Pain—Etoposide—uterine cancer	0.000143	0.00362	CcSEcCtD
Clobetasol propionate—CYP1A2—Estrogen Receptor Pathway—ESR1—uterine cancer	0.000141	0.0127	CbGpPWpGaD
Clobetasol propionate—NR3C1—Nuclear Receptors—ESR1—uterine cancer	0.00014	0.0126	CbGpPWpGaD
Clobetasol propionate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—uterine cancer	0.00014	0.0126	CbGpPWpGaD
Clobetasol propionate—Hyperglycaemia—Doxorubicin—uterine cancer	0.000137	0.00348	CcSEcCtD
Clobetasol propionate—CYP1A1—female gonad—uterine cancer	0.000135	0.0356	CbGeAlD
Clobetasol propionate—CYP1A1—vagina—uterine cancer	0.000134	0.0354	CbGeAlD
Clobetasol propionate—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000133	0.012	CbGpPWpGaD
Clobetasol propionate—Hypoaesthesia—Epirubicin—uterine cancer	0.000131	0.00332	CcSEcCtD
Clobetasol propionate—CYP1A1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000131	0.0118	CbGpPWpGaD
Clobetasol propionate—NR3C1—female gonad—uterine cancer	0.000131	0.0346	CbGeAlD
Clobetasol propionate—NR3C1—vagina—uterine cancer	0.00013	0.0344	CbGeAlD
Clobetasol propionate—Oedema peripheral—Epirubicin—uterine cancer	0.00013	0.00329	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Epirubicin—uterine cancer	0.000129	0.00328	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Etoposide—uterine cancer	0.000123	0.00312	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Doxorubicin—uterine cancer	0.000121	0.00307	CcSEcCtD
Clobetasol propionate—CYP1A1—Tryptophan metabolism—CYP19A1—uterine cancer	0.000121	0.0109	CbGpPWpGaD
Clobetasol propionate—Oedema peripheral—Doxorubicin—uterine cancer	0.00012	0.00304	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Doxorubicin—uterine cancer	0.00012	0.00303	CcSEcCtD
Clobetasol propionate—Pruritus—Etoposide—uterine cancer	0.000118	0.00299	CcSEcCtD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—uterine cancer	0.000118	0.0107	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—uterine cancer	0.000118	0.0107	CbGpPWpGaD
Clobetasol propionate—Alopecia—Epirubicin—uterine cancer	0.000116	0.00295	CcSEcCtD
Clobetasol propionate—Erythema—Epirubicin—uterine cancer	0.000115	0.0029	CcSEcCtD
Clobetasol propionate—NR3C1—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.00011	0.00996	CbGpPWpGaD
Clobetasol propionate—Alopecia—Doxorubicin—uterine cancer	0.000108	0.00273	CcSEcCtD
Clobetasol propionate—CYP1A1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000107	0.0097	CbGpPWpGaD
Clobetasol propionate—NR3C1—Endoderm Differentiation—SMAD3—uterine cancer	0.000107	0.00969	CbGpPWpGaD
Clobetasol propionate—Erythema—Doxorubicin—uterine cancer	0.000106	0.00269	CcSEcCtD
Clobetasol propionate—Rash—Etoposide—uterine cancer	0.000105	0.00267	CcSEcCtD
Clobetasol propionate—Dermatitis—Etoposide—uterine cancer	0.000105	0.00266	CcSEcCtD
Clobetasol propionate—Headache—Etoposide—uterine cancer	0.000105	0.00265	CcSEcCtD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—uterine cancer	0.000102	0.00923	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—AKR1B10—uterine cancer	0.000101	0.00914	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—HMGA1—uterine cancer	9.77e-05	0.00882	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	9.75e-05	0.00881	CbGpPWpGaD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	9.69e-05	0.00246	CcSEcCtD
Clobetasol propionate—CYP1A1—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	9.62e-05	0.00869	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—AKR1B1—uterine cancer	9.41e-05	0.0085	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	9.33e-05	0.00843	CbGpPWpGaD
Clobetasol propionate—Infection—Epirubicin—uterine cancer	9.29e-05	0.00236	CcSEcCtD
Clobetasol propionate—CYP1A2—Arachidonic acid metabolism—AKR1C3—uterine cancer	9.23e-05	0.00834	CbGpPWpGaD
Clobetasol propionate—Skin disorder—Epirubicin—uterine cancer	9.08e-05	0.0023	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	8.96e-05	0.00227	CcSEcCtD
Clobetasol propionate—CYP1A1—lymph node—uterine cancer	8.65e-05	0.0229	CbGeAlD
Clobetasol propionate—Infection—Doxorubicin—uterine cancer	8.6e-05	0.00218	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—ESR1—uterine cancer	8.56e-05	0.00773	CbGpPWpGaD
Clobetasol propionate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—uterine cancer	8.51e-05	0.00768	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	8.45e-05	0.00763	CbGpPWpGaD
Clobetasol propionate—Skin disorder—Doxorubicin—uterine cancer	8.4e-05	0.00213	CcSEcCtD
Clobetasol propionate—Paraesthesia—Epirubicin—uterine cancer	8.4e-05	0.00213	CcSEcCtD
Clobetasol propionate—NR3C1—lymph node—uterine cancer	8.39e-05	0.0222	CbGeAlD
Clobetasol propionate—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	8.34e-05	0.00753	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	8.06e-05	0.00727	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—YWHAE—uterine cancer	8.06e-05	0.00727	CbGpPWpGaD
Clobetasol propionate—Pain—Epirubicin—uterine cancer	8e-05	0.00203	CcSEcCtD
Clobetasol propionate—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	7.91e-05	0.00714	CbGpPWpGaD
Clobetasol propionate—Paraesthesia—Doxorubicin—uterine cancer	7.77e-05	0.00197	CcSEcCtD
Clobetasol propionate—CYP1A2—Tryptophan metabolism—CYP19A1—uterine cancer	7.69e-05	0.00694	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—uterine cancer	7.62e-05	0.00688	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CCL2—uterine cancer	7.54e-05	0.00681	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—ESR2—uterine cancer	7.43e-05	0.00671	CbGpPWpGaD
Clobetasol propionate—Pain—Doxorubicin—uterine cancer	7.4e-05	0.00188	CcSEcCtD
Clobetasol propionate—NR3C1—Adipogenesis—SOCS3—uterine cancer	7.31e-05	0.0066	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—AKR1C1—uterine cancer	6.91e-05	0.00624	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Epirubicin—uterine cancer	6.89e-05	0.00175	CcSEcCtD
Clobetasol propionate—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	6.85e-05	0.00619	CbGpPWpGaD
Clobetasol propionate—Pruritus—Epirubicin—uterine cancer	6.62e-05	0.00168	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CDKN2A—uterine cancer	6.57e-05	0.00593	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—AKR1B10—uterine cancer	6.45e-05	0.00583	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—SMAD3—uterine cancer	6.39e-05	0.00577	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of Androgen receptor activity—EP300—uterine cancer	6.38e-05	0.00576	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Doxorubicin—uterine cancer	6.37e-05	0.00162	CcSEcCtD
Clobetasol propionate—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	6.22e-05	0.00561	CbGpPWpGaD
Clobetasol propionate—NR3C1—Circadian Clock—EP300—uterine cancer	6.2e-05	0.0056	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	6.14e-05	0.00554	CbGpPWpGaD
Clobetasol propionate—Pruritus—Doxorubicin—uterine cancer	6.12e-05	0.00155	CcSEcCtD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—GPX3—uterine cancer	6.06e-05	0.00547	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	6e-05	0.00542	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CXCL8—uterine cancer	5.96e-05	0.00538	CbGpPWpGaD
Clobetasol propionate—Rash—Epirubicin—uterine cancer	5.9e-05	0.00149	CcSEcCtD
Clobetasol propionate—Dermatitis—Epirubicin—uterine cancer	5.89e-05	0.00149	CcSEcCtD
Clobetasol propionate—Headache—Epirubicin—uterine cancer	5.86e-05	0.00149	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CDKN1B—uterine cancer	5.82e-05	0.00525	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—CYP11A1—uterine cancer	5.71e-05	0.00515	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—CYP11A1—uterine cancer	5.63e-05	0.00508	CbGpPWpGaD
Clobetasol propionate—NR3C1—Endoderm Differentiation—CTNNB1—uterine cancer	5.63e-05	0.00508	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CTNNB1—uterine cancer	5.5e-05	0.00496	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	5.48e-05	0.00494	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	5.48e-05	0.00494	CbGpPWpGaD
Clobetasol propionate—Rash—Doxorubicin—uterine cancer	5.46e-05	0.00138	CcSEcCtD
Clobetasol propionate—Dermatitis—Doxorubicin—uterine cancer	5.45e-05	0.00138	CcSEcCtD
Clobetasol propionate—Headache—Doxorubicin—uterine cancer	5.42e-05	0.00137	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—PTEN—uterine cancer	5.36e-05	0.00484	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—AKR1C3—uterine cancer	5.32e-05	0.0048	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—uterine cancer	5.25e-05	0.00474	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	5.14e-05	0.00464	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—EP300—uterine cancer	5.11e-05	0.00461	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	5.07e-05	0.00458	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	5.04e-05	0.00455	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—PHF1—uterine cancer	4.84e-05	0.00437	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—EP300—uterine cancer	4.81e-05	0.00434	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	4.81e-05	0.00434	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	4.55e-05	0.00411	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	4.55e-05	0.00411	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—EP300—uterine cancer	4.5e-05	0.00407	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	4.5e-05	0.00406	CbGpPWpGaD
Clobetasol propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	4.48e-05	0.00404	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	4.4e-05	0.00398	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—CYP19A1—uterine cancer	4.2e-05	0.00379	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—CYP19A1—uterine cancer	4.14e-05	0.00374	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—CHD4—uterine cancer	4.12e-05	0.00372	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	3.87e-05	0.0035	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	3.87e-05	0.00349	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.66e-05	0.00331	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.66e-05	0.00331	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—TP53—uterine cancer	3.66e-05	0.0033	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	3.64e-05	0.00329	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	3.59e-05	0.00324	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—PGR—uterine cancer	3.57e-05	0.00322	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	3.49e-05	0.00315	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	3.49e-05	0.00315	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—SUZ12—uterine cancer	3.45e-05	0.00311	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	3.39e-05	0.00306	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—CTNNB1—uterine cancer	3.35e-05	0.00302	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	3.29e-05	0.00297	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	3.23e-05	0.00292	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—TP53—uterine cancer	3.22e-05	0.00291	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—ESR2—uterine cancer	3.14e-05	0.00284	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—CXCL8—uterine cancer	3.14e-05	0.00283	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	3.07e-05	0.00277	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	3.07e-05	0.00277	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	2.9e-05	0.00262	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	2.9e-05	0.00261	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	2.87e-05	0.00259	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	2.75e-05	0.00248	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—uterine cancer	2.72e-05	0.00246	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—EP300—uterine cancer	2.69e-05	0.00243	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.69e-05	0.00243	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	2.68e-05	0.00242	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	2.64e-05	0.00238	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—CDKN2B—uterine cancer	2.56e-05	0.00231	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—VEGFA—uterine cancer	2.55e-05	0.0023	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	2.47e-05	0.00223	CbGpPWpGaD
Clobetasol propionate—CYP1A1—PPARA activates gene expression—EP300—uterine cancer	2.39e-05	0.00216	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	2.34e-05	0.00212	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.34e-05	0.00211	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.34e-05	0.00211	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—SMAD3—uterine cancer	2.33e-05	0.00211	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—SRD5A2—uterine cancer	2.26e-05	0.00204	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—NDUFB11—uterine cancer	2.26e-05	0.00204	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.19e-05	0.00198	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	2.1e-05	0.00189	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.07e-05	0.00187	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—ESR1—uterine cancer	1.9e-05	0.00172	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—PGR—uterine cancer	1.72e-05	0.00155	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.71e-05	0.00155	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—STAR—uterine cancer	1.63e-05	0.00147	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—AKR1B1—uterine cancer	1.63e-05	0.00147	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—EZH2—uterine cancer	1.63e-05	0.00147	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	1.61e-05	0.00146	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.61e-05	0.00146	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—ESR2—uterine cancer	1.51e-05	0.00137	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.44e-05	0.0013	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.44e-05	0.0013	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.4e-05	0.00126	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.32e-05	0.00119	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—POLD1—uterine cancer	1.28e-05	0.00116	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—CDKN2B—uterine cancer	1.23e-05	0.00111	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—AKR1C1—uterine cancer	1.2e-05	0.00108	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—SMAD3—uterine cancer	1.12e-05	0.00101	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—RRM2—uterine cancer	1.07e-05	0.000964	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—STAR—uterine cancer	1.04e-05	0.000939	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.04e-05	0.000939	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—DCN—uterine cancer	1.04e-05	0.000936	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.03e-05	0.000928	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CYP11A1—uterine cancer	9.76e-06	0.000881	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—AKR1C3—uterine cancer	9.22e-06	0.000832	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—ESR1—uterine cancer	9.17e-06	0.000828	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—POLD1—uterine cancer	8.16e-06	0.000737	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—AKR1C1—uterine cancer	7.63e-06	0.000689	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CYP19A1—uterine cancer	7.18e-06	0.000648	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—STK11—uterine cancer	7.18e-06	0.000648	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—RRM2—uterine cancer	6.8e-06	0.000614	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.74e-06	0.000609	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—DCN—uterine cancer	6.61e-06	0.000597	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.43e-06	0.000581	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CYP11A1—uterine cancer	6.22e-06	0.000562	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—AKR1C3—uterine cancer	5.88e-06	0.000531	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—MTHFR—uterine cancer	5.4e-06	0.000487	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.76e-06	0.000429	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—STK11—uterine cancer	4.58e-06	0.000413	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CYP19A1—uterine cancer	4.58e-06	0.000413	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.3e-06	0.000388	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.1e-06	0.00037	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—MTHFR—uterine cancer	3.44e-06	0.000311	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—AKT1—uterine cancer	3.31e-06	0.000299	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.03e-06	0.000274	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PTEN—uterine cancer	3e-06	0.000271	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—EP300—uterine cancer	2.86e-06	0.000259	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PIK3CA—uterine cancer	2.12e-06	0.000191	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PTEN—uterine cancer	1.91e-06	0.000173	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—EP300—uterine cancer	1.83e-06	0.000165	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—AKT1—uterine cancer	1.73e-06	0.000156	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.35e-06	0.000122	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—AKT1—uterine cancer	1.1e-06	9.96e-05	CbGpPWpGaD
